Skip to main content
. 2015 Jul 15;6(27):23261–23271. doi: 10.18632/oncotarget.4666

Table 3. Proportion of patients with acute-on-chronic hepatitis B liver failure who reach a certain survival time point, given that they have already survived a certain amount of time.

Total survival time If the patient has survived to
1 week 2 weeks 3 weeks 4 weeks 5 weeks 6 weeks 7 weeks 8 weeks 9 weeks 10 weeks 11 weeks 12 weeks
1 week
2 weeks 92.2%
3 weeks 82.6% 89.5%
4 weeks 78.1% 84.7% 94.6%
5 weeks 73.7% 79.9% 89.2% 94.3%
6 weeks 72.2% 78.2% 87.4% 92.4% 98.0%
7 weeks 71.0% 77.0% 86.0% 90.9% 96.5% 98.4%
8 weeks 69.9% 75.8% 84.7% 89.5% 94.9% 96.9% 98.4%
9 weeks 67.7% 73.4% 81.9% 86.6% 91.9% 93.8% 95.2% 96.8%
10 weeks 66.5% 72.1% 80.6% 85.2% 90.3% 92.2% 93.7% 95.2% 98.3%
11 weeks 66.2% 71.7% 80.1% 84.7% 89.8% 91.7% 93.1% 94.6% 97.8% 99.4%
12 weeks 66.2% 71.7% 80.1% 84.7% 89.8% 91.7% 93.1% 94.6% 97.8% 99.4% 100.0%
13 weeks 65.4% 70.9% 79.2% 83.7% 88.8% 90.6% 92.1% 93.5% 96.7% 98.3% 98.9% 98.9%